Standardised coding is needed for reports of adverse drug reactions

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7033.776c (Published 23 March 1996) Cite this as: BMJ 1996;312:776
  1. J M Bonnetblanc,
  2. J C Roujeau,
  3. C Benichou
  1. Head Department of Dermatology, University Hospital Dupuytren, 87042 Limoges cedex, France
  2. Professor Department of Dermatology, University Hospital Henri Mondor, 994010 Creteil cedex
  3. Director International Drug Monitoring Department, Synthelabo, BP 110, 92225 Bagneux cedex

    EDITOR,—Reports of adverse drug reactions make up a considerable proportion of the medical literature. Adverse reactions to recently marketed drugs may not have been detected during premarketing studies, and information about such reactions must be transmitted rapidly to all prescribers. This is usually achieved for serious reactions, but knowledge of milder reactions is often restricted to specialists.

    Data on …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription